There is no doubt that the field of cancer immunotherapy is attracting a great deal of attention from investors and big pharma companies alike these days. With plenty of deals being racked up in this space, Berkeley, Calif.-based Aduro Biotech Inc. is the latest company to forge a major collaboration based on immuno-oncology research.